Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 913 - 920 of 11617 results
DHS Publishes Proposed H-1B Regulations
October 23, 2023| Alert| Viewpoint
Leveraging A Law Firm To Create Impact with Steve Osborn of Mintz
October 20, 2023| News
Foreshadowing Biden’s AI Executive Order? — AI: The Washington Report
October 20, 2023| Article| Viewpoint
Massachusetts Paid Family and Medical Leave Updates – What Employers Need to Know
October 19, 2023| Blog| Viewpoint
New York Widens its Employee Intellectual Property Protections
October 19, 2023| Blog| Viewpoint
Market Advised to Proceed With Fund Names Rule Compliance
October 18, 2023| News
Supporting a Road to Recovery for Injured War Survivors
October 17, 2023| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.